Article
Experimental evolution of Saccharomyces cerevisiae for caffeine tolerance alters multidrug resistance and target of rapamycin signaling pathways.
G3 (Bethesda, Md.) - 4 Sept 2024
Geck Renee C, Moresi Naomi G, Anderson Leah M, Brewer Rebecca, Renz Timothy R, Taylor Matthew Bryce, Dunham Maitreya J
Abstract excerpt
Caffeine is a natural compound that inhibits the major cellular signaling regulator target of rapamycin (TOR), leading to widespread effects including growth inhibition. Saccharomyces cerevisiae yeast can adapt to tolerate high concentrations of caffeine in coffee and cacao fermentations and in experimental systems. While many factors affecting caffeine tolerance and TOR signaling have been identified, further...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
